Detail

Study ID: ACCRU GU-1703 Genitourinary

Title:

Randomized, Phase II Trial of Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC)

Description:
We want to find out what effects, good and/or bad, Vitamin C (ascorbic acid) has on you and your clear cell renal cancer. This study is taking place to find out if taking Vitamin C (ascorbic acid) along with the chemotherapy drug Pazopanib is better for your cancer than just Pazopanib alone.
Location:
Fargo Region
Principal Investigator:
Preston Steen, MD
Disease:
Other, REN (Renal)
Stage:
Unknown
Status:
Active - Open to Accrual